Selection of Nexium, Prilosec and Other PPI Lawsuits for Bellwether Process Debated By Parties
Plaintiffs and defendants in heartburn drug lawsuits are sparring over the bellwether trial selection process.…
«
»
Plaintiffs and defendants in heartburn drug lawsuits are sparring over the bellwether trial selection process.…
Two lots of Relpax, a migraine medication, are being recalled because of the risk of bacterial contamination.…
The makers of popular heartburn drugs like Nexium, Prilosec and Prevacid face more than 13,000 claims of health problems linked to their products.…
The FDA is warning that Pfizer’s ulcerative colitis drug, Xeljanz, could cause pulmonary embolism and deep vein thrombosis at higher doses.…
Side effects of the rheumatoid arthritis and ulcerative colitis drug Xeljanz may result in the development of serious and potentially lethal pulmonary embolism. Lawsuits are being reviewed by lawyers nationwide.…
Neurontin and similar drugs are linked to an increased risk of suicide, overdose and violent behavior, according to the findings of a new study.…
The manufacturers of Nexium, Prilosec, Prevacid and similar heartburn drugs are asking a federal judge to remove stomach cancer cases from mass litigation pretrial proceedings involving other injuries linked to the popular medications.…
Recent studies have found that side effects of Viagra may increase the risk of melanoma, a serious and potentially deadly form of skin cancer. Lawsuits are now being reviewed for men nationwide who may have avoided problems from melanoma if warnings had been provided. STATUS OF VIAGRA MELANOMA LAWSUITS: Product liability lawyers are providing free consultations and case evaluations for men diagnosed with melanoma following use of Viagra, to determine whether financial compensation may be available through a lawsuit. MANUFACTURER: Pfizer OVERVIEW: Viagra (sildenafil citrate) was approved in 1998 for the treatment of erectile dysfunction. The widely used drug generates…
Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…